Dr Jonathan Troy Balagna, MD | |
4007 Gateway Blvd Ste 100, Newburgh, IN 47630-8947 | |
(812) 842-0907 | |
(812) 490-7051 |
Full Name | Dr Jonathan Troy Balagna |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 11 Years |
Location | 4007 Gateway Blvd Ste 100, Newburgh, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1871932442 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | R1698 (Texas) | Secondary |
207RI0011X | Internal Medicine - Interventional Cardiology | 01085761A (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Deaconess Hospital Inc | Evansville, IN | Hospital |
Methodist Hospital | Henderson, KY | Hospital |
Gibson General Hospital | Princeton, IN | Hospital |
Carle Richland Memorial Hospital | Olney, IL | Hospital |
Fairfield Memorial Hospital 1 | Fairfield, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Deaconess Specialty Physicians, Inc | 0244595205 | 89 |
Deaconess Hospital Inc | 9032021431 | 308 |
Deaconess Specialty Physicians, Inc | 0244595205 | 89 |
Deaconess Specialty Physicians, Inc | 0244595205 | 89 |
News Archive
K-V Pharmaceutical Company today issued an update on the status of the U.S. Food and Drug Administration's review of Hologic, Inc.'s New Drug Application for Gestiva as a treatment for the prevention of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.
A breakthrough in microscopy and endoscopy will soon revolutionize the study of the cellular origin of diseases, advancing the field of precision medicine. This is the goal of CRIMSON, a trans-disciplinary and trans-national research project recently funded by European Commission.
Virtual Reality can get the elderly in nursing homes to be happier about exercising. A new research project from Aalborg University shows that the technology motivates older people in nursing homes to get moving.
A major new research program supported by the Innovative Medicines Initiative launches today, which will develop new ways of monitoring major depressive disorder, epilepsy, and multiple sclerosis using wearable devices and smartphone technology.
› Verified 2 days ago
Entity Name | Deaconess Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427097443 PECOS PAC ID: 9032021431 Enrollment ID: O20040115000129 |
News Archive
K-V Pharmaceutical Company today issued an update on the status of the U.S. Food and Drug Administration's review of Hologic, Inc.'s New Drug Application for Gestiva as a treatment for the prevention of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.
A breakthrough in microscopy and endoscopy will soon revolutionize the study of the cellular origin of diseases, advancing the field of precision medicine. This is the goal of CRIMSON, a trans-disciplinary and trans-national research project recently funded by European Commission.
Virtual Reality can get the elderly in nursing homes to be happier about exercising. A new research project from Aalborg University shows that the technology motivates older people in nursing homes to get moving.
A major new research program supported by the Innovative Medicines Initiative launches today, which will develop new ways of monitoring major depressive disorder, epilepsy, and multiple sclerosis using wearable devices and smartphone technology.
› Verified 2 days ago
Entity Name | Deaconess Specialty Physicians, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1306344817 PECOS PAC ID: 0244595205 Enrollment ID: O20180702001637 |
News Archive
K-V Pharmaceutical Company today issued an update on the status of the U.S. Food and Drug Administration's review of Hologic, Inc.'s New Drug Application for Gestiva as a treatment for the prevention of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.
A breakthrough in microscopy and endoscopy will soon revolutionize the study of the cellular origin of diseases, advancing the field of precision medicine. This is the goal of CRIMSON, a trans-disciplinary and trans-national research project recently funded by European Commission.
Virtual Reality can get the elderly in nursing homes to be happier about exercising. A new research project from Aalborg University shows that the technology motivates older people in nursing homes to get moving.
A major new research program supported by the Innovative Medicines Initiative launches today, which will develop new ways of monitoring major depressive disorder, epilepsy, and multiple sclerosis using wearable devices and smartphone technology.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jonathan Troy Balagna, MD Po Box 1230, Evansville, IN 47706-1230 Ph: (812) 450-6815 | Dr Jonathan Troy Balagna, MD 4007 Gateway Blvd Ste 100, Newburgh, IN 47630-8947 Ph: (812) 842-0907 |
News Archive
K-V Pharmaceutical Company today issued an update on the status of the U.S. Food and Drug Administration's review of Hologic, Inc.'s New Drug Application for Gestiva as a treatment for the prevention of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.
A breakthrough in microscopy and endoscopy will soon revolutionize the study of the cellular origin of diseases, advancing the field of precision medicine. This is the goal of CRIMSON, a trans-disciplinary and trans-national research project recently funded by European Commission.
Virtual Reality can get the elderly in nursing homes to be happier about exercising. A new research project from Aalborg University shows that the technology motivates older people in nursing homes to get moving.
A major new research program supported by the Innovative Medicines Initiative launches today, which will develop new ways of monitoring major depressive disorder, epilepsy, and multiple sclerosis using wearable devices and smartphone technology.
› Verified 2 days ago
Dr. Robert Ernest Swaney Iii, MD, MSPH, FACP Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3699 Epworth Rd, Newburgh, IN 47630 Phone: 812-471-1200 | |
Dr. Maruthi Srikanth Penumetsa, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4007 Gateway Blvd # 100, Newburgh, IN 47630 Phone: 812-842-0907 Fax: 812-490-7919 | |
Dr. Frank X Pamelia, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 4007 Gateway Blvd, Ste100, Newburgh, IN 47630 Phone: 812-842-0907 Fax: 812-490-5536 | |
Dr. Prasanna Lakshmi Yelamanchili, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4007 Gateway Blvd, Ste 100, Newburgh, IN 47630 Phone: 812-842-0907 Fax: 812-490-7054 | |
Dr. Leslie Rae Pike Brown, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3699 Epworth Rd, Newburgh, IN 47630 Phone: 812-471-1200 | |
Mr. Mohammad Bashar Mourad, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9355 Warrick Trl, Newburgh, IN 47630 Phone: 270-689-1919 Fax: 270-689-1990 | |
Mr. Ashwin Sabarivijay Durairaj, M.D Internal Medicine Medicare: Medicare Enrolled Practice Location: 4007 Gateway Blvd, Newburgh, IN 47630 Phone: 812-464-9133 Fax: 812-464-0559 |